Bain Capital Sells Emcure Stake to Norway's Wealth Fund as Shares Dip

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Bain Capital Sells Emcure Stake to Norway's Wealth Fund as Shares Dip
Overview

Global investment firm Bain Capital sold a nearly 1% stake in Emcure Pharmaceuticals for ₹289.47 crore in an open market sale. The sale led to a 2.31% drop in Emcure's stock price to ₹1,690. Norway's Government Pension Fund Global acquired the identical stake at the same price, showing continued investor interest. Emcure Pharmaceuticals recently reported a strong 48% year-on-year increase in its Q3 profit.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Block Deal Divestment

Bain Capital, through its affiliate BC Investments IV Ltd, offloaded 18 lakh shares, representing a 0.95% stake in Pune-based Emcure Pharmaceuticals. The transaction, valued at ₹289.47 crore, saw shares sold at an average price of ₹1,608.20 apiece on Wednesday.

Market Reaction

The sale contributed to a 2.31% decline in Emcure Pharmaceuticals' stock, which traded at ₹1,690 on the National Stock Exchange. Bain Capital's holding in Emcure has now reduced to 2.93% from 3.87% following this transaction.

Sovereign Fund Acquisition

Simultaneously, Norway's Government Pension Fund Global, one of the world's largest sovereign wealth funds, stepped in to purchase the exact same quantity of shares at the identical price, absorbing the stake sold by Bain Capital.

Emcure's Financial Performance

Emcure Pharmaceuticals also reported strong financial results. For the third quarter ended December 31, 2025, the company posted a consolidated profit after tax of ₹231 crore, a significant 48% increase from the ₹156 crore recorded in the same period last fiscal year. Revenue from operations also rose to ₹2,363 crore from ₹1,963 crore year-on-year.

Prior Sales

This is not the first time Bain Capital has reduced its stake in Emcure. In July 2025, the investment firm had previously sold a 2.4% stake for ₹563 crore.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.